This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Stora Enso Interim Review January-September 2009 2009-10-22 03:26 ET - News Release
-- EUR 216 million cash flow after capital expenditure: strongest
quarter since fourth quarter of 2006
-- Improved EUR 132 million operating profit excluding NRI and fair
valuations; includes EUR -28 million non-cash impact from
2003-2009 wood supply inventory error
-- EUR 655 million non-recurring items, including EUR 71 million
future cash impact, due to earlier announced impairment and
restructuring costs
-- Market outlook remains weak for fourth quarter of 2009
Summary of Third Quarter Results
---------------------------------------------------------------------
Continuing Operations Q3/09 Q2/09 Q3/08
---------------------------------------------------------------------
Sales EUR 2 231.0 2 184.8 2 722.7
million
---------------------------------------------------------------------
EBITDA excl. NRI and fair EUR 255.9 190.4 302.1
valuations million
---------------------------------------------------------------------
Operating Profit excl. NRI EUR 131.5 48.5 125.5
and Fair Valuations million
---------------------------------------------------------------------
Operating loss (IFRS) EUR -502.6 -209.4 -138.7
million
---------------------------------------------------------------------
Profit before tax excl. NRI EUR 106.4 47.2 117.8
million
---------------------------------------------------------------------
Loss before tax EUR -548.7 -370.6 -161.7
million
---------------------------------------------------------------------
Net profit excl. NRI EUR 92.5 44.9 116.5
million
---------------------------------------------------------------------
Net loss EUR -519.7 -368.3 -119.1
million
---------------------------------------------------------------------
EPS excl. NRI EUR 0.12 0.06 0.14
---------------------------------------------------------------------
EPS EUR -0.66 -0.46 -0.16
---------------------------------------------------------------------
CEPS excl. NRI EUR 0.29 0.24 0.37
---------------------------------------------------------------------
ROCE excl. NRI % 7.7 2.8 5.4
---------------------------------------------------------------------
ROCE excl. NRI and fair % 6.6 2.3 4.9
valuations
---------------------------------------------------------------------
Fair valuations include synthetic options net of realised and open
hedges, CO2 emission rights, and valuations of biological assets
mainly related to associated companies' forest assets.
NRI = Non-recurring items. These are exceptional transactions that
are not related to normal business operations. The most common
non-recurring items are capital gains, additional write-downs,
provisions for planned restructuring and penalties. Non-recurring
items are normally specified individually if they exceed one cent
per share.
The remainder is available to Stockwatch subscribers. If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |